Tempus AI (TEM) Revenue & Revenue Breakdown
Tempus AI Revenue Highlights
Latest Revenue (Y)
$531.82M
Latest Revenue (Q)
$334.21M
Tempus AI Revenue by Period
Tempus AI Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $531.82M | 65.85% |
| 2022-12-31 | $320.67M | 24.36% |
| 2021-12-31 | $257.85M | 37.15% |
| 2020-12-31 | $188.00M | 202.95% |
| 2019-12-31 | $62.06M | - |
Tempus AI generated $531.82M in revenue during NA 2023, up 65.85% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Tempus AI Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $334.21M | 6.22% |
| 2025-06-30 | $314.63M | 23.03% |
| 2025-03-31 | $255.74M | 27.44% |
| 2024-12-31 | $200.68M | 10.92% |
| 2024-09-30 | $180.93M | 9.01% |
| 2024-06-30 | $165.97M | 13.82% |
| 2024-03-31 | $145.82M | -1.29% |
| 2023-12-31 | $147.72M | 8.58% |
| 2023-09-30 | $136.06M | 2.75% |
| 2023-06-30 | $132.42M | 14.52% |
| 2023-03-31 | $115.62M | 14.90% |
| 2022-12-31 | $100.63M | 37.26% |
| 2021-12-31 | $73.31M | 39.78% |
| 2021-09-30 | $52.45M | -48.00% |
| 2020-12-31 | $100.85M | 98.79% |
| 2020-09-30 | $50.73M | - |
Tempus AI generated $334.21M in revenue during Q3 2025, up 6.22% compared to the previous quarter, and up 201.37% compared to the same period a year ago.
Tempus AI Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CNC | Centene | $163.07B | $49.69B |
| FMS | Fresenius Medical Care AG & Co. KGaA | $19.45B | $4.72B |
| UHS | Universal Health Services | $15.83B | $4.50B |
| ICLR | ICON Public | $8.12B | $2.09B |
| SNN | Smith & Nephew | $5.55B | $2.79B |
| HOLX | Hologic | $4.10B | - |
| COO | Cooper Companies | $4.09B | $1.06B |
| NBIX | Neurocrine Biosciences | $2.36B | $794.90M |
| MEDP | Medpace | $2.11B | $659.90M |
| DOCS | Doximity | $570.40M | $145.91M |
| TEM | Tempus AI | $531.82M | $334.21M |